Table 2.
Knowledge dimension distribution.
| Knowledge | Know | Partially know | Do not know |
|---|---|---|---|
| K1. Pain is a common complication after SCI. | 165 (41%) | 182 (45.3%) | 55 (13.7%) |
| K2. NP refers to pain caused by damage or disease affecting the somatosensory system. | 130 (32.3%) | 203 (50.5%) | 69 (17.2%) |
| K3. Pain screening for SCI patients should be conducted continuously during admission, hospitalization, and follow-up after discharge. | 128 (31.8%) | 174 (43.3%) | 100 (24.9%) |
| K4. Are you familiar with the International Spinal Cord Injury Pain Basic Data Set (ISCIPBDS)? | 52 (12.9%) | 138 (34.3%) | 212 (52.7%) |
| K5. All SCI patients should undergo pain assessment. The following scales can be used for NP assessment: | |||
| K5.1 DN4 and I-DN4 | 125 (31.1%) | 11 (2.7%) | 266 (66.2%) |
| K5.2 LANSS and S-LANSS | 87 (21.6%) | 21 (5.2%) | 294 (73.1%) |
| K5.3 PainDETECT | 105 (26.1%) | 12 (3%) | 285 (70.9%) |
| K5.4 NPQ | 100 (24.9%) | 13 (3.2%) | 289 (71.9%) |
| K5.5 ID pain | 117 (29.1%) | 10 (2.5%) | 275 (68.4%) |
| K6. Electrophysiological tests play an important role in the diagnosis of NP. The following tests are helpful for NP assessment: | |||
| K6.1 Nerve conduction studies | 263 (65.4%) | 2 (0.5%) | 137 (34.1%) |
| K6.2 F-waves and H-reflexes | 161 (40%) | 15 (3.7%) | 226 (56.2%) |
| K6.3 Quantitative sensory testing | 202 (50.2%) | 10 (2.5%) | 190 (47.3%) |
| K6.4 Skin sympathetic response | 205 (51%) | 15 (3.7%) | 182 (45.3%) |
| K7. The following imaging studies help diagnose NP: | |||
| K7.1 Computed tomography | 205 (51%) | 48 (11.9%) | 149 (37.1%) |
| K7.2 Magnetic resonance imaging | 260 (64.7%) | 13 (3.2%) | 129 (32.1%) |
| K7.3 Functional magnetic resonance imaging | 196 (48.8%) | 17 (4.2%) | 189 (47%) |
| K7.4 Positron emission tomography-computed tomography | 177 (44%) | 50 (12.4%) | 175 (43.5%) |
| K8. Pain is related to psychological states such as anxiety and depression. PHQ-9 and GAD-7 are commonly used for psychological assessment in NP patients. | 109 (27.1%) | 140 (34.8%) | 153 (38.1%) |
| K9. Management of NP requires a principle of comprehensive management and multidisciplinary collaboration. | 135 (33.6%) | 136 (33.8%) | 131 (32.6%) |
| K10. First-line medications for NP include: | |||
| K10.1 Anticonvulsants | 167 (41.5%) | 41 (10.2%) | 194 (48.3%) |
| K10.2 Antidepressants | 178 (44.3%) | 37 (9.2%) | 187 (46.5%) |
| K10.3 Opioids | 209 (52%) | 37 (9.2%) | 156 (38.8%) |
| K10.4 Topical analgesics | 246 (61.2%) | 20 (5%) | 136 (33.8%) |
| K11. Minimally invasive interventional treatments for NP include: | |||
| K11.1 Nerve blocks | 250 (62.2%) | 22 (5.5%) | 130 (32.3%) |
| K11.2 Pulsed radiofrequency | 234 (58.2%) | 18 (4.5%) | 150 (37.3%) |
| K11.3 Neurolysin | 196 (48.8%) | 32 (8%) | 174 (43.3%) |
| K12. Neuromodulation treatments for NP include neurostimulation and intrathecal drug delivery. | 109 (27.1%) | 127 (31.6%) | 166 (41.3%) |
| K13. Surgical treatments for NP mainly involve nerve decompression and neurodestruction. | 100 (24.9%) | 137 (34.1%) | 165 (41%) |
| K14. Are you familiar with the following NP treatments: | |||
| K14.1 Psychotherapy | 108 (26.9%) | 157 (39.1%) | 137 (34.1%) |
| K14.2 Rehabilitation therapy | 151 (37.6%) | 155 (38.6%) | 96 (23.9%) |
| K14.3 Physical therapy | 144 (35.8%) | 154 (38.3%) | 104 (25.9%) |
| K14.4 Gene therapy | 77 (19.2%) | 104 (25.9%) | 221 (55%) |
SCI: spinal cord injury; NP: neuropathic pain.
Note: The questionnaire was designed and administered in Chinese. The English translation was not validated and is provided for indicative purposes only.